> top > docs > PMC:7205724 > spans > 1380-1550 > annotations

PMC:7205724 / 1380-1550 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
51 130-133 Gene denotes IL6 Gene:3569
60 63-71 Species denotes patients Tax:9606
64 87-98 Chemical denotes Tocilizumab MESH:C502936
76 77-85 Disease denotes COVID-19 MESH:C000657245

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T5 113-121 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T17 77-85 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T5 100-101 http://purl.obolibrary.org/obo/CLO_0001020 denotes a

LitCovid-sample-MedDRA

Id Subject Object Predicate Lexical cue meddra_id
T3 34-44 http://purl.bioontology.org/ontology/MEDDRA/10022891 denotes viral load http://purl.bioontology.org/ontology/MEDDRA/10062178

LitCovid-sample-PD-NCBITaxon

Id Subject Object Predicate Lexical cue ncbi_taxonomy_id
T17 77-85 Species denotes COVID-19 NCBItxid:2697049

LitCovid-sample-Pubtator

Id Subject Object Predicate Lexical cue pubann:denotes
60 63-71 Species denotes patients Tax:9606
76 77-85 Disease denotes COVID-19 MESH:C000657245
64 87-98 Chemical denotes Tocilizumab MESH:C502936
51 130-133 Gene denotes IL6 Gene:3569

LitCovid-sample-UniProt

Id Subject Object Predicate Lexical cue uniprot_id
T177 130-133 Protein denotes IL6 https://www.uniprot.org/uniprot/Q9XT80|https://www.uniprot.org/uniprot/Q9UCU4|https://www.uniprot.org/uniprot/Q9UCU3|https://www.uniprot.org/uniprot/Q9UCU2|https://www.uniprot.org/uniprot/Q9MZR1|https://www.uniprot.org/uniprot/Q9MYZ7|https://www.uniprot.org/uniprot/Q95KN6|https://www.uniprot.org/uniprot/Q95181|https://www.uniprot.org/uniprot/Q90YI0|https://www.uniprot.org/uniprot/Q8MKH0|https://www.uniprot.org/uniprot/Q8BN26|https://www.uniprot.org/uniprot/Q865X6|https://www.uniprot.org/uniprot/Q865W7|https://www.uniprot.org/uniprot/Q6V919|https://www.uniprot.org/uniprot/Q6L6X6|https://www.uniprot.org/uniprot/Q5I6E3|https://www.uniprot.org/uniprot/Q3UCQ0|https://www.uniprot.org/uniprot/Q2MH06|https://www.uniprot.org/uniprot/Q28819|https://www.uniprot.org/uniprot/Q28747|https://www.uniprot.org/uniprot/Q28319|https://www.uniprot.org/uniprot/Q25BC2|https://www.uniprot.org/uniprot/Q0PW36|https://www.uniprot.org/uniprot/Q0GGL7|https://www.uniprot.org/uniprot/Q08DT2|https://www.uniprot.org/uniprot/P79341|https://www.uniprot.org/uniprot/P51494|https://www.uniprot.org/uniprot/P46650|https://www.uniprot.org/uniprot/P41693|https://www.uniprot.org/uniprot/P41683|https://www.uniprot.org/uniprot/P41323|https://www.uniprot.org/uniprot/P29455|https://www.uniprot.org/uniprot/P26893|https://www.uniprot.org/uniprot/P26892|https://www.uniprot.org/uniprot/P20607|https://www.uniprot.org/uniprot/P08505|https://www.uniprot.org/uniprot/P05231|https://www.uniprot.org/uniprot/O46568|https://www.uniprot.org/uniprot/O35736|https://www.uniprot.org/uniprot/O19007|https://www.uniprot.org/uniprot/B6CKP4|https://www.uniprot.org/uniprot/A9QWQ9|https://www.uniprot.org/uniprot/A3FBE9|https://www.uniprot.org/uniprot/A0S0B0

LitCovid-sample-Enju

Id Subject Object Predicate Lexical cue
T208 6-10 IN denotes with
T209 11-19 NN denotes severity
T210 19-20 -COMMA- denotes ,
T211 21-32 NN denotes criticality
T212 32-33 -COMMA- denotes ,
T213 34-39 JJ denotes viral
T214 40-44 NN denotes load
T215 44-45 -COMMA- denotes ,
T216 46-49 CC denotes and
T217 50-59 NN denotes prognosis
T218 60-62 IN denotes of
T219 63-71 NNS denotes patients
T220 72-76 IN denotes with
T221 77-85 NN denotes COVID-19
T222 87-98 NNP denotes Tocilizumab
T223 98-99 -COMMA- denotes ,
T224 100-101 DT denotes a
T225 102-112 JJ denotes monoclonal
T226 113-121 NN denotes antibody
T227 122-129 IN denotes against
T228 130-133 NN denotes IL6
T229 133-134 -COMMA- denotes ,
T230 135-140 MD denotes could
T231 141-147 VB denotes confer
T232 148-156 JJ denotes clinical
T233 157-164 NN denotes benefit
T234 165-167 IN denotes in
R200 T209 T208 arg2Of severity,with
R201 T209 T210 arg1Of severity,","
R202 T211 T210 arg2Of criticality,","
R204 T214 T212 arg2Of load,","
R205 T214 T213 arg1Of load,viral
R206 T216 T215 arg1Of and,","
R207 T212 T216 arg1Of ",",and
R208 T217 T216 arg2Of prognosis,and
R209 T217 T218 arg1Of prognosis,of
R210 T219 T218 arg2Of patients,of
R211 T219 T220 arg1Of patients,with
R212 T221 T220 arg2Of COVID-19,with
R213 T222 T223 arg1Of Tocilizumab,","
R214 T226 T223 arg2Of antibody,","
R215 T226 T224 arg1Of antibody,a
R216 T226 T225 arg1Of antibody,monoclonal
R217 T226 T227 arg1Of antibody,against
R218 T228 T227 arg2Of IL6,against
R219 T231 T229 arg1Of confer,","
R220 T222 T230 arg1Of Tocilizumab,could
R221 T231 T230 arg2Of confer,could
R222 T222 T231 arg1Of Tocilizumab,confer
R223 T233 T231 arg2Of benefit,confer
R224 T233 T232 arg1Of benefit,clinical
R225 T231 T234 arg1Of confer,in

LitCovid-sample-PD-FMA

Id Subject Object Predicate Lexical cue fma_id
T5 113-121 Body_part denotes antibody http://purl.org/sig/ont/fma/fma62871

LitCovid-sample-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T17 77-85 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096